Source: Annual Congress 2010 - COPD: management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Yohannes, T. Willgoss, J. Vestbo (United Kingdom). Tiotropium for the treatment of stable chronic obstructive pulmonary disease: A meta-analysis of clinically relevant outcomes. Eur Respir J 2010; 36: Suppl. 54, 4009

Member's Comments

No comment yet.

Related content which might interest you: Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 A preliminary meta-analysis of long-term inhaled steroids for stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001 The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Tiotropium in the management of chronic obstructive pulmonary disease Source: Eur Respir J 2002; 19: 205-206 Year: 2002 Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): A two-year study Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease Source: Eur Respir J 2004; 23: 241-249 Year: 2004 Tiotropium in chronic obstructive pulmonary disease: Gender differences in outcomes Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 The utility of tiotropium among patients with chronic obstructive pulmonary disease (COPD): An updated meta-analysis of randomized controlled trials Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 Comparison of patient-reported outcomes (PROs) during acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Early supported discharge/hospital at home for exacerbation of chronic obstructive pulmonary disease, A review and meta-analysis Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Proactive integrated care improves quality of life in patients with COPD Source: Eur Respir J 2009; 33: 1031-1038 Year: 2009 Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial Source: Eur Respir J 2002; 19: 936-943 Year: 2002 Long-term health status in patients with poorly reversible chronic obstructive pulmonary disease (COPD) treated with cilomilast Source: Eur Respir J 2004; 24: Suppl. 48, 540s Year: 2004 Azithromycin to prevent exacerbations of chronic obstructive pulmonary disease: a study in the real-world setting Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 Oral theophylline benefits stable 'irreversible' chronic obstructive pulmonary disease: a systematic review and meta-analysis Source: Eur Respir J 2002; 20: Suppl. 38, 374s Year: 2002